Lung cancer symptoms

Lung Cancer Symptoms

What are the first symptoms of lung cancer? Is it something that you can tell early on the course so that you have a better prognosis?

Generally most people with lung cancer will present with symptoms related to the respiratory tract. This all depends on the location of the tumor, how large and extensive the cancer is and how it impacts the surrounding tissue structures like the heart.

The most common symptoms are :

a persistent cough that doesn't go away.
having breathing problems
exercise intolerance - probably related to the breathing difficulties
pain in the chest - this often only occurs in the late stages of the lung cancer.

Gates And Bloomberg Unite In Global Fight Against Tobacco

Two of the world's richest philanthropists, Bill Gates and Michael Bloomberg pledged on Wednesday to spend 500 million dollars to make people all over the world stop smoking. They announced the news together at a press conference at the TheTimesCenter in Midtown Manhattan. Michael Bloomberg is mayor of New York City and founder of Bloomberg LP, a giant financial software services, news and data company.

Gene Panel Predicts Lung Cancer Survival

Researchers from four leading cancer centers have confirmed that an analysis involving a panel of genes can be used to predict which lung cancer patients will have the worst survival. The finding could one day lead to a test that would help determine who needs more aggressive treatment. The study, the largest of its kind, appears online in Nature Medicine.

BioNumerik Pharmaceuticals Observes Evidence Of A Survival Increase In Lung Cancer Patients Participating In Tavocept(TM) Clinical Trial

BioNumerik Pharmaceuticals, Inc. ("BioNumerik") announced that patients with adenocarcinoma (the most frequently occurring form of lung cancer) participating in a Phase II clinical trial of Tavocept(TM) showed a survival increase of approximately 198 days (6.5 months). The trial observations included an approximate 40% reduction in mortality for adenocarcinoma patients receiving Tavocept.

Anti-Tobacco Campaign Tests Lung Capacity, Determination And Tobacco Awareness In 'Miley Mania Adventure'

Pop culture, anti-tobacco awareness and physical endurance merged last Friday in The TRUTH's 'Miley Mania Adventure' in Salt Lake City. Twenty parent-child teams faced six anti-tobacco riddles that lead them to scavenge over 50 miles of the Wasatch Front with nothing more than their own two feet and the local public transit system.

Greater Gains In Mortality Reduction From Common Cancers Associated With Higher Education

Deaths due to the four most common cancers - lung, colorectal, prostate, and breast - have dropped substantially in the United States from 1993 to 2001 in working-aged individuals. However, not all Americans are equally likely to benefit from those gains.

Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine Or Vinorelbine In Performance Status (PS 2) NSCLC Patients

Cell Therapeutics, Inc. (CTI) announced the publication of results from its randomized phase III trial comparing OPAXIO(TM) (paclitaxel poliglumex, CT-2103) with gemcitabine or vinorelbine for the treatment of PS 2 (performance status 2) patients with previously untreated non-small cell lung cancer (NSCLC) in the Journal of Thoracic Oncology (Volume 3, Number 7, July 2008). Results showed that overall survival was similar between the two arms (hazard ratio of 0.

A Report By Leading Clinical Researchers On The Current Quantitative Imaging Tools For Lung Cancer Drug Assessment

Research and Markets has announced the addition of the "Quantitative Imaging Tools for Lung Cancer Drug Assessment" report to their offering.

Circulating Tumor Cells Can Reveal Genetic Signature Of Dangerous Lung Cancers

Massachusetts General Hospital (MGH) investigators have shown that an MGH-developed, microchip-based device that detects and analyzes tumor cells in the bloodstream can be used to determine the genetic signature of lung tumors, allowing identification of those appropriate for targeted treatment and monitoring genetic changes that occur during therapy.

Linking Second-Hand Smoke And Lung Cancer

It is a widely accepted notion that second-hand smoke (SHS) is linked to lung cancer. However, medical professionals and researchers have not reached consensus on the extent of the increase in cancer risk due to SHS.

Smokeless Tobacco Can Also Increase Cancer Risk

A review published in The Lancet Oncology finds that although users of smokeless tobacco products (STPs) likely have a lower cancer risk than smokers, they are still increasing their risk of developing several types of cancer. In the USA and Sweden, a finely cut or powered, flavored tobacco called moist snuff is the most popular form of STP used. In places like India, there is a wide range of products that are regularly consumed.

A Healthy You
Health information at your finger tips. Thanks for dropping by.